Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  13. 8-K Event Delisting notice
  14. 8-K Event Delisting notice · Executive or director change
  15. 8-K Event Executive or director change
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. ARS Other Annual Report to Security Holders
  19. DEFA14A Proxy Proxy Materials
  20. DEF 14A Proxy Proxy Statement

Page 6 of 18 · 348 filings